Atlas Trials

Evaluation of AMG 714 for Vitiligo

Clinical trial NCT04338581 · COMPLETED

Trial details

NCT number
NCT04338581
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Vitiligo
Start date
2020-12-11
Primary completion
2024-10-16
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.